valor de las acciones
Competidores
| Simbolo bursátil | Precio | Pronóstico 1A | Pronóstico 2A | Cap. Mercado | Div Yld | Tasa de crecimiento |
|---|---|---|---|---|---|---|
|
CPSE:NOVO B
Novo Nordisk A/S
|
910.00 | -1.79% | 18.59% | 4,053,901.21 | 1.03% | 18.5% |
|
NYSE:JNJ
Johnson & Johnson
|
151.38 | 0% | 0% | 364,323.09 | 3.28% | 2.71% |
|
NYSE:MRK
Merck
|
128.66 | -8.25% | 5.21% | 325,870.86 | 2.38% | -19.03% |
|
LSE:AZN
AstraZeneca PLC
|
122.46 | 17.57% | 40.04% | 189,841.78 | 2% | 15.98% |
|
SWX:NOVN
Novartis
|
93.49 | 8.01% | 21.37% | 190,757.59 | 3.55% | 4.67% |
|
NYSE:ABT
Abbott Laboratories
|
104.01 | 2.51% | 15.26% | 180,939.31 | 2.1% | 9.04% |
|
NYSE:PFE
Pfizer
|
28.38 | 9.41% | 39.92% | 160,817.91 | 5.91% | -9.31% |
|
ENXTPA:SAN
Sanofi
|
91.69 | 16.05% | 34.5% | 114,488.32 | 4.06% | 8.19% |
|
NasdaqGS:VRTX
Vertex Pharmaceuticals Inc
|
428.59 | 1.69% | 9.74% | 110,599.1 | 0% | 30.14% |
|
LSE:GSK
GSK
|
18.10 | 5.36% | 20.88% | 73,812.48 | 3.2% | 0.79% |
|
NasdaqGS:GILD
Gilead Sciences Inc
|
67.65 | 21.02% | 30.29% | 84,281.97 | 4.56% | 0.15% |
|
TSE:4502
Takeda Pharmaceutical Company
|
4205.00 | 0% | 0% | 6,597,366.84 | 4.78% | 0% |
|
NasdaqGS:BIIB
Biogen
|
226.88 | -13.85% | 1.44% | 33,033.02 | 0% | -10.89% |
|
XTRA:BAYN
Bayer
|
29.22 | 63.87% | 79.86% | 28,706.43 | 0.37% | 1.47% |
|
ENXTBR:UCB
UCB
|
120.25 | -38.25% | -9.7% | 22,817.51 | 1.11% | -2.55% |
|
NYSE:BAX
Baxter International Inc
|
35.24 | 82.83% | 110.41% | 17,957.61 | 3.27% | -3.14% |
|
TSE:4503
Astellas Pharma
|
1521.00 | 0% | 0% | 2,727,132.35 | 4.9% | 0% |
|
OM:SOBI
Swedish Orphan Biovitrum AB (publ)
|
283.40 | -19.96% | 11.4% | 96,386.6 | 0% | -1.05% |
|
SHSE:600161
Beijing Tiantan Biological Products
|
30.43 | 33.91% | 62.95% | 50,093.41 | 0.5% | 14.53% |
|
SZSE:002252
Shanghai RAAS Blood Products
|
7.51 | 0% | 0% | 49,666.85 | 0.41% | 14.87% |
